Medicine & Life Sciences
Brain
100%
ATP Binding Cassette Transporter, Subfamily B, Member 1
93%
Blood-Brain Barrier
88%
Glioblastoma
81%
Brain Neoplasms
63%
Pharmaceutical Preparations
48%
Microdialysis
48%
Pharmacokinetics
41%
Central Nervous System
41%
Breast Neoplasms
36%
Heterografts
36%
Elacridar
34%
Neoplasms
30%
Neoplasm Metastasis
24%
Melanoma
24%
Proteins
24%
Poloxamer
24%
Glioma
22%
In Vitro Techniques
22%
Multidrug Resistance-Associated Proteins
20%
ATP Binding Cassette Transporter, Subfamily G, Member 2
20%
abacavir
17%
Microvessels
16%
Probenecid
15%
Therapeutics
15%
Dasatinib
15%
depatuxizumab mafodotin
14%
zosuquidar trihydrochloride
14%
Temozolomide
14%
Knockout Mice
14%
SAR405838
14%
ispinesib
13%
Pemetrexed
12%
Permeability
12%
Zidovudine
12%
ErbB Receptors
12%
Erlotinib Hydrochloride
11%
Convection
11%
cediranib
11%
Rhodamine 123
11%
ponatinib
10%
Cyclosporine
10%
Human immunodeficiency virus 1 p16 protease
10%
palbociclib
10%
Panobinostat
10%
Ataxia Telangiectasia
10%
HIV Protease Inhibitors
10%
Sunitinib
10%
Phosphotransferases
10%
Chemical Compounds
Drug
35%
Pharmacokinetics
25%
Resistance
24%
Protein
20%
Abacavir
19%
Clearance
18%
Plasma
17%
Pluronic
15%
Zidovudine
15%
Cyclosporin A
14%
Probenecid
13%
Rhodamine 123
12%
Pemetrexed
11%
Sampling
10%
5-Fluorouracil
10%
Erlotinib
10%
Permeability
10%
Fluconazole
8%
Fluorescein
7%
Probe
7%
Bioavailability
7%
Application
7%
Organic Anion
7%
Glycoprotein P Inhibitor
7%
Trametinib
6%
Agmatine
6%
Nucleoside
6%
Dose
6%
Palbociclib
6%
Glycol
5%
Nelfinavir
5%
D-Methionine
5%
Partition Coefficient
5%
Sunitinib
5%
Propene
5%
Intracerebral
5%
Monolayer
5%
Block Copolymer
5%
EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinase) Inhibitor
5%
Plasma Concentration
5%
Vd
5%
Sorafenib
5%